Detailed answers about ANDREWS OLIGONUCLEOTIDE CONSULTING LTD, including incorporation, status, business activity, and accounts information.
When was ANDREWS OLIGONUCLEOTIDE CONSULTING LTD founded?
ANDREWS OLIGONUCLEOTIDE CONSULTING LTD was officially incorporated on 27 October 2026 and is registered under company number 17545040. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ANDREWS OLIGONUCLEOTIDE CONSULTING LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ANDREWS OLIGONUCLEOTIDE CONSULTING LTD?
ANDREWS OLIGONUCLEOTIDE CONSULTING LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ANDREWS OLIGONUCLEOTIDE CONSULTING LTD do?
ANDREWS OLIGONUCLEOTIDE CONSULTING LTD operates in the following sectors: 70229 - Management consultancy activities other than financial management, 71122 - Engineering related scientific and technical consulting activities. These SIC codes provide insight into the company's business activities and industry focus.
What is ANDREWS OLIGONUCLEOTIDE CONSULTING LTD's registered address?
The registered office address of ANDREWS OLIGONUCLEOTIDE CONSULTING LTD is 36 Dents Close, Letchworth Garden City, England, SG6 2TP. This is the official address filed with Companies House for legal and statutory correspondence.
Is ANDREWS OLIGONUCLEOTIDE CONSULTING LTD financially stable?
Financial accounts for ANDREWS OLIGONUCLEOTIDE CONSULTING LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.